Attached files

file filename
EX-32.2 - EX-32.2 - ALNYLAM PHARMACEUTICALS, INC.alny-ex322_6.htm
EX-32.1 - EX-32.1 - ALNYLAM PHARMACEUTICALS, INC.alny-ex321_7.htm
EX-31.2 - EX-31.2 - ALNYLAM PHARMACEUTICALS, INC.alny-ex312_8.htm
EX-31.1 - EX-31.1 - ALNYLAM PHARMACEUTICALS, INC.alny-ex311_9.htm
EX-23.1 - EX-23.1 - ALNYLAM PHARMACEUTICALS, INC.alny-ex231_1020.htm
EX-10.14 - EX-10.14 - ALNYLAM PHARMACEUTICALS, INC.alny-ex1014_989.htm
10-K - 10-K - ALNYLAM PHARMACEUTICALS, INC.alny-10k_20161231.htm

EXHIBIT 21.1

SUBSIDIARIES OF THE REGISTRANT

 

 

 

 

 

 

 

Name

 

Ownership Percentage

 

Jurisdiction of Organization

Alnylam U.S., Inc.

 

100%

 

Delaware

Alnylam Securities Corporation

 

100%

 

Massachusetts

Sirna Therapeutics, Inc.

 

100%

 

Delaware

Alnylam (Bermuda) Ltd.

 

100%

 

Bermuda

Alnylam France S.A.S

 

100%

 

France

Alnylam Europe AG

 

100%

 

Germany

Alnylam Germany GmbH

 

100%

 

Germany

Alnylam Italy S.r.l.

 

100%

 

Italy

Alnylam Sweden AB

 

100%

 

Sweden

Alnylam Switzerland GmbH

 

100%

 

Switzerland

Alnylam UK Limited

 

100%

 

United Kingdom